Estela Rodriguez and Coral Olazagasti
Feb 4, 2025, 14:41
Estela Rodriguez: Coral Olazagasti discussed ALK+ lung cancer primary resistance to ALK TKIs
Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of the Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center, shared a post on X:
“Excellent case presented by Coral Olazagasti discussing ALK+ lung cancer primary resistance to ALK TKIs and what to do when our usual therapies stop working.
Key points:
-repeat biopsies and NGS is a key,
-refer to clinical trials early.
-discuss palliative care.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 14, 2025, 05:21
Mar 13, 2025, 14:26
Mar 13, 2025, 10:43
Mar 13, 2025, 10:14
Mar 13, 2025, 10:06
Mar 13, 2025, 09:32
Mar 13, 2025, 09:10
Mar 13, 2025, 09:07
Mar 13, 2025, 08:55